98%
921
2 minutes
20
Objective: To investigate the epidemiological profile and spatial distribution of human visceral leishmaniasis cases in Crateús, Ceará, Brazil, from 2007 to 2023.
Methods: This was a retrospective, descriptive cross-sectional study based on epidemiologic data from the Notifiable Health Conditions Information System regarding human visceral leishmaniasis in Crateús between 2007 and 2023. The variables assessed were sex, age group at the time of diagnosis, race/skin color, education level, HIV coinfection, case outcome, neighborhood of residence, area of residence, and number of deaths per year of notification. Relative frequency, incidence, and lethality rates were calculated; maps were created to reflect the spatial distribution of cases within the municipality.
Results: Between 2007 and 2023, 112 cases of visceral leishmaniasis were reported in Crateús, predominantly among males (n=77), brown-skinned individuals (n=81), aged 20-39 years (n=27), with incomplete elementary education (n=31), and residing in urban areas of the municipality (n=88). The incidence rate decreased from 22.81 in 2007 to 16.02 in 2008, with a peak of 14.67 in 2018; by 2023, the incidence rate had dropped to 10.47. There were four cases of HIV coinfection and two deaths directly attributable to the disease.
Conclusion: Cases of visceral leishmaniasis in Crateús were concentrated in the urban area of the municipality. The epidemiologic profile was consistent with national trends, with the most affected individuals being of mixed race/skin color, male, aged 20-39 years, and with incomplete elementary education.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1590/S2237-96222025v34e20250155.en | DOI Listing |
Chem Biol Drug Des
September 2025
Laboratory of Biochemistry and Animal Toxins, Institute of Biotechnology, Federal University of Uberlandia, Uberlandia, MG, Brazil.
Leishmaniasis, a disease caused by Leishmania parasites, poses a significant health threat globally, particularly in Latin America and Brazil. Leishmania amazonensis is an important species because it is associated with both cutaneous leishmaniasis and an atypical visceral form. Current treatments are hindered by toxicity, resistance, and high cost, driving the need for new therapeutic targets and drugs.
View Article and Find Full Text PDFPLoS Negl Trop Dis
September 2025
Institute of Immunology & Infection Research, University of Edinburgh, Ashworth Laboratories, Edinburgh, United Kingdom.
Background: Neglected tropical diseases (NTDs) are a group of 21 diseases affecting approximately 1.5 billion people globally. Significant progress has been made in their control: by March 2024, 50 countries had eliminated at least one NTD, with 13 of these countries eliminating at least two.
View Article and Find Full Text PDFPLoS One
September 2025
University of Montpellier, CNRS, IRD, Academic Hospital (CHU) of Montpellier, MiVEGEC, Montpellier, France.
Parasites of the Leishmania donovani complex are responsible for visceral leishmaniasis, a vector-borne disease transmitted through the bite of female phlebotomine sand flies. As well as the human hosts, these parasites infect many mammals which can serve as reservoirs. Dogs are particularly important reservoirs.
View Article and Find Full Text PDFEpidemiol Serv Saude
September 2025
Universidade Estadual do Ceará, Faculdade de Educação e Ciências Integradas de Crateús, Crateús, CE, Brazil.
Objective: To investigate the epidemiological profile and spatial distribution of human visceral leishmaniasis cases in Crateús, Ceará, Brazil, from 2007 to 2023.
Methods: This was a retrospective, descriptive cross-sectional study based on epidemiologic data from the Notifiable Health Conditions Information System regarding human visceral leishmaniasis in Crateús between 2007 and 2023. The variables assessed were sex, age group at the time of diagnosis, race/skin color, education level, HIV coinfection, case outcome, neighborhood of residence, area of residence, and number of deaths per year of notification.
Epidemiol Serv Saude
August 2025
Empresa Brasileira de Serviços Hospitalares, Brasília, DF, Brazil.